MYC and prostate neoplasm: In summary, focusing on CpG sites from exon 3 to the 3′ UTR of MYC, our results suggested lower MYC DNA methylation in prostate tumor compared to paired normal prostate tissue, and lower exon 3 DNA methylation for more aggressive compared to less aggressive tumors.